布鲁氏菌病
怀孕
利福平
流产
布鲁氏菌
医学
流产胎儿
布鲁氏菌
产科
胎儿
胎盘
免疫学
肺结核
生物
病理
遗传学
作者
Jaffar A. Al‐Tawfiq,Ziad A. Memish
出处
期刊:Recent Patents on Anti-infective Drug Discovery
[Bentham Science]
日期:2013-02-01
卷期号:8 (1): 47-50
被引量:36
标识
DOI:10.2174/1574891x11308010009
摘要
Brucellosis is a zoonotic infection caused by Brucella spp. In endemic countries, the disease does not spare the pregnant. There is evidence that brucellosis can induce abortion in humans. Positive cultures of brucella from human placenta, aborted fetuses, and other products of conception were reported previously. It is speculated that brucellosis causes fewer spontaneous abortions in humans than animals due to the absence of Erythritol in the human placenta and fetus. In addition, the presence of anti-brucella activity in human amniotic fluid may also play a role. Rifampin is considered the mainstay of treatment of brucellosis during pregnancy, in various combinations. In a retrospective study of brucellosis in pregnancy, antepartum treatment with antimicrobial agents was more protective against the occurrence of abortion than no or inadequate treatment. It seems that the incidence of abortion is not different among patients treated with either trimethoprim-sulfamethoxazole with or without rifampicin. With therapy during pregnancy, the overall success rate resulting in normal delivery is 90%. The article discussed few of the patents associated with brucellosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI